Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Whole Genome Rare-Variant Association Study of HIV-1 Progression in a Southern African Population

Prisca K. Thami, Wonderful Choga, Delesa D. Mulisa, Collet Dandara, Andrey K. Shevchenko, Melvin M. Leteane, Vlad Novitsky, Stephen J. O’Brien, Myron Essex, Simani Gaseitsiwe, Emile R. Chimusa
doi: https://doi.org/10.1101/2020.12.16.20248307
Prisca K. Thami
1Division of Human Genetics, Department of Pathology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, 7925, South Africa
2Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wonderful Choga
1Division of Human Genetics, Department of Pathology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, 7925, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Delesa D. Mulisa
1Division of Human Genetics, Department of Pathology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, 7925, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Collet Dandara
1Division of Human Genetics, Department of Pathology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, 7925, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrey K. Shevchenko
3Theodosius Dobzhansky Center for Genome Bioinformatics, St. Petersburg State University, St. Petersburg 199034, Russia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Melvin M. Leteane
4Department of Biological Sciences, University of Botswana, Gaborone, Botswana
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vlad Novitsky
5Harvard T.H. Chan School of Public Health AIDS Initiative, Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, 02115, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen J. O’Brien
6Laboratory of Genomics Diversity, Center for Computer Technologies, ITMO University, St. Petersburg, 197101, Russia
7Guy Harvey Oceanographic Center Halmos College of Natural Sciences and Oceanography Nova Southeastern University, Ft Lauderdale, Florida, 33004, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Myron Essex
5Harvard T.H. Chan School of Public Health AIDS Initiative, Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, 02115, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simani Gaseitsiwe
2Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana
5Harvard T.H. Chan School of Public Health AIDS Initiative, Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, 02115, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emile R. Chimusa
1Division of Human Genetics, Department of Pathology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, 7925, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: emile.chimusa@uct.ac.za
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Despite the high burden of HIV-1 in Botswana, the population of Botswana is significantly underrepresentation in host genetics studies of HIV-1. Furthermore, the bulk of previous genomics studies evaluated common human genetic variations, however, there is increasing evidence of the influence of rare variants in the outcome of diseases which may be uncovered by comprehensive complete and deep genome sequencing. This research aimed to evaluate the role of rare-variants in susceptibility to HIV-1 and progression through whole genome sequencing. Whole genome sequences (WGS) of 265 HIV-1 positive and 125 were HIV-1 negative unrelated individuals from Botswana were mapped to the human reference genome GRCh38. Population joint variant calling was performed using Genome Analysis Tool Kit (GATK) and BCFTools. Cumulative effects of rare variant sets on susceptibility to HIV-1 and progression (CD4+ T-cell decline) were determined with optimized Sequence Kernel Association Test (SKAT-O). In silico functional analysis of the prioritized variants was performed through gene-set enrichment using databases in GeneMANIA and Enrichr. Novel rare-variants within the ANKRD39 (8.48 × 10−8), LOC105378523 (7.45 × 10−7) and GTF3C3 (1.36 × 10−6) genes were significantly associated with HIV-1 progression. Functional analysis revealed that these genes are involved in viral translation and transcription. These findings highlight the significance of whole genome sequencing in pinpointing rare-variants of clinical relevance. The research contributes towards a deeper understanding of the host genetics HIV-1 and offers promise of population specific interventions against HIV-1.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was funded in part by the Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE), a DELTAS Africa Initiative [grant # DEL-15-006], through the Wellcome Trust [grant # 107752/Z/15/Z].

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study is part of a bigger protocol titled Host Genetics of HIV-1 Subtype C Infection, Progression and Treatment in Africa/GWAS on determinants of HIV-1 Subtype C Infection, conducted by Botswana Harvard AIDS Institute Partnership. Ethics approval was obtained according to The Declaration of Helsinki. All participants consented to participate in the study. Institutional Review Board (IRB) approval was obtained for these samples from Botswana Ministry of Health and Wellness - Health Research Development Committee (HRDC) & Harvard School of Public Health IRB (reference number: HPDME 13/18/1) and the University of Cape Town - Human Research Ethics Committee (HREC reference number: 316/2019).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Requests to access the sequence data should be addressed to sgaseitsiwe{at}bhp.org.bw

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted December 18, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Whole Genome Rare-Variant Association Study of HIV-1 Progression in a Southern African Population
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Whole Genome Rare-Variant Association Study of HIV-1 Progression in a Southern African Population
Prisca K. Thami, Wonderful Choga, Delesa D. Mulisa, Collet Dandara, Andrey K. Shevchenko, Melvin M. Leteane, Vlad Novitsky, Stephen J. O’Brien, Myron Essex, Simani Gaseitsiwe, Emile R. Chimusa
medRxiv 2020.12.16.20248307; doi: https://doi.org/10.1101/2020.12.16.20248307
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Whole Genome Rare-Variant Association Study of HIV-1 Progression in a Southern African Population
Prisca K. Thami, Wonderful Choga, Delesa D. Mulisa, Collet Dandara, Andrey K. Shevchenko, Melvin M. Leteane, Vlad Novitsky, Stephen J. O’Brien, Myron Essex, Simani Gaseitsiwe, Emile R. Chimusa
medRxiv 2020.12.16.20248307; doi: https://doi.org/10.1101/2020.12.16.20248307

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Genetic and Genomic Medicine
Subject Areas
All Articles
  • Addiction Medicine (271)
  • Allergy and Immunology (556)
  • Anesthesia (135)
  • Cardiovascular Medicine (1766)
  • Dentistry and Oral Medicine (238)
  • Dermatology (173)
  • Emergency Medicine (314)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (661)
  • Epidemiology (10809)
  • Forensic Medicine (8)
  • Gastroenterology (594)
  • Genetic and Genomic Medicine (2959)
  • Geriatric Medicine (288)
  • Health Economics (534)
  • Health Informatics (1932)
  • Health Policy (836)
  • Health Systems and Quality Improvement (745)
  • Hematology (293)
  • HIV/AIDS (632)
  • Infectious Diseases (except HIV/AIDS) (12524)
  • Intensive Care and Critical Care Medicine (696)
  • Medical Education (300)
  • Medical Ethics (87)
  • Nephrology (324)
  • Neurology (2805)
  • Nursing (152)
  • Nutrition (433)
  • Obstetrics and Gynecology (559)
  • Occupational and Environmental Health (597)
  • Oncology (1472)
  • Ophthalmology (444)
  • Orthopedics (172)
  • Otolaryngology (257)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (381)
  • Pediatrics (868)
  • Pharmacology and Therapeutics (367)
  • Primary Care Research (338)
  • Psychiatry and Clinical Psychology (2646)
  • Public and Global Health (5381)
  • Radiology and Imaging (1015)
  • Rehabilitation Medicine and Physical Therapy (597)
  • Respiratory Medicine (727)
  • Rheumatology (330)
  • Sexual and Reproductive Health (290)
  • Sports Medicine (279)
  • Surgery (327)
  • Toxicology (48)
  • Transplantation (150)
  • Urology (126)